Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic.

ABSTRACT:

Objectives

During the coronavirus disease 2019 (COVID-19) pandemic, public debates overtly addressed the promises of new innovative drugs. Many of these debates pitted those who advocated for the development of new drugs by pharmaceutical companies against those who favored the repositioning of existing drugs. Our study explored perceptions of the association between drug novelty and effectiveness as well as perceptions of the role of the pharmaceutical industry in drug development.

Methods

Data were collected in January 2021 from a quota sample of the French population aged 18-75years (n=1,000) during the second round of the "Health Literacy Survey 2019" (HLS₁₉).

Results

We tested the hypothesis that individuals with a high level of familiarity with the he

SUBMITTER: Schultz E 

PROVIDER: S-EPMC9077798 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature